Stratification of Liver Stiffness according to eGFR in the MAFLD group. Dahkki Zienab M. Saad (22676502)

Fáttát:

Medication-inclusive multivariable logistic regression for MAFLD. Dahkki Zienab M. Saad (22676502)

Fáttát:

Receiver operating characteristic (ROC) curve analysis comparing the performance of non-invasive fibrosis scores in MAFLD patients. Dahkki Zienab M. Saad (22676502)

Fáttát:

Comparison of Non-invasive Liver Fibrosis Scores. Dahkki Zienab M. Saad (22676502)

Fáttát:

A. Violin plots showing eGFR distribution in MAFLD (red) vs. non-MAFLD (blue) groups. Dahkki Zienab M. Saad (22676502)

Fáttát:

Proposed pathophysiological crosstalk between MAFLD and CKD. Dahkki Zienab M. Saad (22676502)

Fáttát:

Liver Stiffness and Fibrosis Grading by MAFLD Status. Dahkki Zienab M. Saad (22676502)

Fáttát:

2D–shear-wave elastography example: MAFLD + CKD case (female, 57 years). Dahkki Zienab M. Saad (22676502)

Fáttát:

Grades of liver fibrosis in MAFLD group (grey) and non-MAFLD group (black). Dahkki Zienab M. Saad (22676502)

Fáttát:

Multivariable logistic regression models for MAFLD predictors. Dahkki Zienab M. Saad (22676502)

Fáttát:

Liver Fibrosis Characteristics by CKD Stage in MAFLD Patients (n = 64). Dahkki Zienab M. Saad (22676502)

Fáttát: